Congenital cytomegalovirus infection: Clinical presentation, epidemiology, diagnosis and prevention

Obstetric Medicine

Volumn 7, Issue 4, 2014, Pages 140-146

  van Zuylen, Wendy J ^a,b   Hamilton, Stuart T ^a,c   Naing, Zin ^a,b   Hall, Beverly ^a   Shand, Antonia ^d   Rawlinson, William D ^a,b,c  

^a PRINCE OF WALES HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d ROYAL HOSPITAL FOR WOMEN   (Australia)

Author keywords

Infection; infectious diseases; maternal fetal medicine; neonatal medicine

Indexed keywords

CHORIORETINITIS; CYTOMEGALOVIRUS INFECTION; DISEASE TRANSMISSION; HEPATOMEGALY; HUMAN; IMMUNOCOMPROMISED PATIENT; JAUNDICE; LYMPHOCYTOSIS; MATERNAL CARE; MATERNAL SERUM SCREENING TEST; MENTAL DEFICIENCY; MICROCEPHALY; MONONUCLEOSIS; OPTIC NERVE ATROPHY; PERCEPTION DEAFNESS; PETECHIA; POLYMERASE CHAIN REACTION; PRECONCEPTION INJURY; PREECLAMPSIA; RANDOMIZED CONTROLLED TRIAL (TOPIC); REINFECTION; REVIEW; RISK FACTOR; SEIZURE; SEROCONVERSION; SEROPREVALENCE; SPLENOMEGALY; STRABISMUS; THROMBOCYTOPENIA; VIRUS REACTIVATION; VISUAL IMPAIRMENT;

EID: 84911959125     PISSN: 1753495X     EISSN: 17534968     Source Type: Journal    
DOI: 10.1177/1753495X14552719     Document Type: Review

References (86)

1. Manicklal S,Emery VC,Lazzarotto T,.The “silent” global burden of congenital cytomegalovirus.Clin Microbiol Rev. 2013;26:86-102
2. Crough T,Khanna R.Immunobiology of human cytomegalovirus: From bench to bedside.Clin Microbiol Rev. 2009;22:76-98
3. Cannon MJ,Hyde TB,Schmid DS.Review of cytomegalovirus shedding in bodily fluids and relevance to congenital cytomegalovirus infection.Rev Med Virol. 2011;21:240-255
4. Adler SP.Molecular epidemiology of cytomegalovirus: A study of factors affecting transmission among children at three day-care centers.Pediatr Infect Dis J. 1991;10:584-590
5. Slobedman B,Cao JZ,Avdic S,.Human cytomegalovirus latent infection and associated viral gene expression.Future Microbiol. 2010;5:883-900
6. Mocarski E,Shenk T,Pass RFields virology. 5th ed. Philadelphia: Lippincott Williams & Wilkins, 2007, pp. 2701–2772.Knipe DHowley PGriffin D, ed. Philadelphia: Lippincott Williams & Wilkins; 2007:2701-2772.
7. Knowles WA,Gardner SD,Fox H.A comparison of cervical cytomegalovirus (CMV) excretion in gynaecological patients and post-partum women.Arch Virol. 1982;73:25-31
8. Pignatelli S,Dal Monte P,Rossini G,.Genetic polymorphisms among human cytomegalovirus (HCMV) wild-type strains.Rev Med Virol. 2004;14:383-410
9. Renzette N,Gibson L,Bhattacharjee B,.Rapid intrahost evolution of human cytomegalovirus is shaped by demography and positive selection.PLoS Genet. 2013;9:e1003735-e1003735
10. Nigro G,Anceschi MM,Cosmi EV.Clinical manifestations and abnormal laboratory findings in pregnant women with primary cytomegalovirus infection.BJOG. 2003;110:572-577
11. van Zuijlen W.Cytomegalovirus and ageing of the immune system: A controversial cause of ageing.Microbiology Australia. 2013;34:157-159
12. Wills MR,Mason GM,Sissons PCytomegaloviruses: From molecular pathogenesis to intervention. Reddehase MJ, ed. Norfolk: Caister Academic Press; 2013:142-172.
13. Cannon MJ,Schmid DS,Hyde TB.Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection.Rev Med Virol. 2010;20:202-213
14. Basha J,Iwasenko JM,Robertson P,.Congenital cytomegalovirus infection is associated with high maternal socio-economic status and corresponding low maternal cytomegalovirus seropositivity.J Paediatr Child Health. 2014;50:368-372
15. Hyde TB,Schmid DS,Cannon MJ.Cytomegalovirus seroconversion rates and risk factors: implications for congenital CMV.Rev Med Virol. 2010;20:311-326
16. Wang C,Zhang X,Bialek S,.Attribution of congenital cytomegalovirus infection to primary versus non-primary maternal infection.Clin Infect Dis. 2011;52:e11-13
17. Mussi-Pinhata MM,Yamamoto AY,Moura Brito RM,.Birth prevalence and natural history of congenital cytomegalovirus infection in a highly seroimmune population.Clin Infect Dis. 2009;49:522-528
18. McDonagh S,Maidji E,Ma W,.Viral and bacterial pathogens at the maternal-fetal interface.J Infect Dis. 2004;190:826-834
19. Dollard SC,Grosse SD,Ross DS.New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection.Rev Med Virol. 2007;17:355-363
20. Kenneson A,Cannon MJ.Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection.Rev Med Virol. 2007;17:253-276
21. McMullan BJ,Palasanthiran P,Jones CA,.Congenital cytomegalovirus – time to diagnosis, management and clinical sequelae in Australia: opportunities for earlier identification.Med J Aust. 2011;194:625-629
22. Munro SC,Hall B,Whybin LR,.Diagnosis of and screening for cytomegalovirus infection in pregnant women.J Clin Microbiol. 2005;43:4713-4718
23. Lanzieri TM,Dollard SC,Bialek SR,.Systematic review of the birth prevalence of congenital cytomegalovirus infection in developing countries.Int J Infect Dis. 2014;22C:44-48
24. Zureick-Brown S,Newby H,Chou D,.Understanding global trends in maternal mortality.Int Perspect Sex Reprod Health. 2013;39:32-41
25. Pass RF,Fowler KB,Boppana SB,.Congenital cytomegalovirus infection following first trimester maternal infection: symptoms at birth and outcome.J Clin Virol. 2006;35:216-220
26. de Vries JJ,van Zwet EW,Dekker FW,.The apparent paradox of maternal seropositivity as a risk factor for congenital cytomegalovirus infection: A population-based prediction model.Rev Med Virol. 2013;23:241-249
27. Iwasenko JM,Howard J,Arbuckle S,.Human cytomegalovirus infection is detected frequently in stillbirths and is associated with fetal thrombotic vasculopathy.J Infect Dis. 2011;203:1526-1533
28. Pereira L, Petitt M, Fong A, et al. Intrauterine growth restriction caused by underlying congenital cytomegalovirus infection. J Infect Dis 2014; 10: 1573–1584.
29. Williams EJ,Embleton ND,Clark JE,.Viral infections: contributions to late fetal death, stillbirth, and infant death.J Pediatr. 2013;163:424-428
30. Lorenzoni F, Lunardi S, Liumbruno A, et al. Neonatal screening for congenital cytomegalovirus infection in preterm and small for gestational age infants. J Matern Fetal Neonatal Med 2014; 15: 1589–1593.
31. Xie F,Hu Y,Magee LA,.An association between cytomegalovirus infection and pre-eclampsia: A case-control study and data synthesis.Acta Obstet Gynecol Scand. 2010;89:1162-1167
32. Boppana SB,Pass RF,Britt WJ,.Symptomatic congenital cytomegalovirus infection: neonatal morbidity and mortality.Pediatr Infect Dis J. 1992;11:93-99
33. Dahl HH,Ching TY,Hutchison W,.Etiology and audiological outcomes at 3 years for 364 children in Australia.PLoS One. 2013;8:e59624-e59624
34. Gabrielli L,Bonasoni MP,Lazzarotto T,.Histological findings in foetuses congenitally infected by cytomegalovirus.J Clin Virol. 2009;46:S16-21
35. Scott GM,Chow SS,Craig ME,.Cytomegalovirus infection during pregnancy with maternofetal transmission induces a proinflammatory cytokine bias in placenta and amniotic fluid.J Infect Dis. 2012;205:1305-1310
36. Hamilton ST,Scott G,Naing Z,.Human cytomegalovirus-induces cytokine changes in the placenta with implications for adverse pregnancy outcomes.PLoS One. 2012;7:e52899-e52899
37. Maidji E,Nigro G,Tabata T,.Antibody treatment promotes compensation for human cytomegalovirus-induced pathogenesis and a hypoxia-like condition in placentas with congenital infection.Am J Pathol. 2010;177:1298-1310
38. Cannon MJ,Westbrook K,Levis D,.Awareness of and behaviors related to child-to-mother transmission of cytomegalovirus.Prev Med. 2012;54:351-357
39. Baer HR,McBride HE,Caviness AC,.Survey of congenital cytomegalovirus (cCMV) knowledge among medical students.J Clin Virol. 2014;60:222-242
40. Jeon J,Victor M,Adler SP,.Knowledge and awareness of congenital cytomegalovirus among women.Infect Dis Obstet Gynecol. 2006;2006:80383-80383
41. Adler SP.Cytomegalovirus and child day care: Risk factors for maternal infection.Pediatr Infect Dis J. 1991;10:590-594
42. Reichman O and Miskin I. Preconception screening for cytomegalovirus: An effective preventive approach. BioMed Research International 2014; 2014: 135416.
43. Wilson J,Jungner GPublic Health Paper. Geneva: World Health Organization; 1968:34-34.
44. Walker SP,Palma-Dias R,Wood EM,.Cytomegalovirus in pregnancy: To screen or not to screen.BMC Pregnancy Childbirth. 2013;13:96-96
45. Cannon MJ, Griffiths PD, Aston V, et al. Universal newborn screening for congenital CMV infection: What is the evidence of potential benefit? Rev Med Virol 2014; 5: 291–307.
46. Rahav G.Congenital cytomegalovirus infection—A question of screening.Isr Med Assoc J. 2007;9:392-394
47. Forsgren M.Prevention of congenital and perinatal infections.Euro Surveill. 2009;14:2-4
48. Rajasekariah H,Scott G,Robertson PW,.Improving diagnosis of primary cytomegalovirus infection in pregnant women using immunoblots.J Med Virol. 2013;85:315-319
49. Stagno S,Tinker MK,Elrod C,.Immunoglobulin M antibodies detected by enzyme-linked immunosorbent assay and radioimmunoassay in the diagnosis of cytomegalovirus infections in pregnant women and newborn infants.J Clin Microbiol. 1985;21:930-935
50. BaAlawi F,Robertson PW,Lahra M,.Comparison of five CMV IgM immunoassays with CMV IgG avidity for diagnosis of primary CMV infection.Pathology. 2012;44:381-383
51. Enders G,Daiminger A,Bader U,.The value of CMV IgG avidity and immunoblot for timing the onset of primary CMV infection in pregnancy.J Clin Virol. 2013;56:102-107
52. Lazzarotto T,Varani S,Spezzacatena P,.Maternal IgG avidity and IgM detected by blot as diagnostic tools to identify pregnant women at risk of transmitting cytomegalovirus.Viral Immunol. 2000;13:137-141
53. Revello MG,Fabbri E,Furione M,.Role of prenatal diagnosis and counseling in the management of 735 pregnancies complicated by primary human cytomegalovirus infection: A 20-year experience.J Clin Virol. 2011;50:303-307
54. Guerra B,Simonazzi G,Puccetti C,.Ultrasound prediction of symptomatic congenital cytomegalovirus infection.Am J Obstet Gynecol. 2008;198:380 e381-387
55. Picone O,Teissier N,Cordier AG,.Detailed in utero ultrasound description of 30 cases of congenital cytomegalovirus infection.Prenat Diagn. 2014;34:518-524
56. Benoist G,Salomon LJ,Jacquemard F,.The prognostic value of ultrasound abnormalities and biological parameters in blood of fetuses infected with cytomegalovirus.BJOG. 2008;115:823-829
57. Yinon Y,Farine D,Yudin MH,.Cytomegalovirus infection in pregnancy.J Obstet Gynaecol Can. 2010;32:348-354
58. Azam AZ,Vial Y,Fawer CL,.Prenatal diagnosis of congenital cytomegalovirus infection.Obstet Gynecol. 2001;97:443-448
59. Liesnard C,Donner C,Brancart F,.Prenatal diagnosis of congenital cytomegalovirus infection: Prospective study of 237 pregnancies at risk.Obstet Gynecol. 2000;95:881-888
60. Lazzarotto T,Varani S,Guerra B,.Prenatal indicators of congenital cytomegalovirus infection.J Pediatr. 2000;137:90-95
61. Guerra B,Lazzarotto T,Quarta S,.Prenatal diagnosis of symptomatic congenital cytomegalovirus infection.Am J Obstet Gynecol. 2000;183:476-482
62. Adler SP.Screening for cytomegalovirus during pregnancy.Infect Dis Obstet Gynecol. 2011;2011:1-9
63. Boppana SB,Ross SA,Shimamura M,.Saliva polymerase-chain-reaction assay for cytomegalovirus screening in newborns.N Engl J Med. 2011;364:2111-2118
64. Belec L,Brogan TV.Real-time PCR-based testing of saliva for cytomegalovirus at birth.Expert Rev Anti Infect Ther. 2011;9:1119-1124
65. McIver CJ,Jacques CF,Chow SS,.Development of multiplex PCRs for detection of common viral pathogens and agents of congenital infections.J Clin Microbiol. 2005;43:5102-5110
66. Revello MG,Gerna G.Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant.Clin Microbiol Rev. 2002;15:680-715
67. Schleiss MR.Acquisition of human cytomegalovirus infection in infants via breast milk: Natural immunization or cause for concern?.Rev Med Virol. 2006;16:73-82
68. Centers for Disease Control and Prevention. Cytomegalovirus and congenital Infection—Interpretation of laboratory tests, http://www.cdc.gov/cmv/clinical/lab-tests.html (accessed May 2014).
69. Pass RF,Zhang C,Evans A,.Vaccine prevention of maternal cytomegalovirus infection.N Engl J Med. 2009;360:1191-1199
70. Jacquemard F,Yamamoto M,Costa JM,.Maternal administration of valaciclovir in symptomatic intrauterine cytomegalovirus infection.BJOG. 2007;114:1113-1121
71. Roxby AC,Atkinson C,Asbjornsdottir K,.Maternal valacyclovir and infant cytomegalovirus acquisition: A randomized controlled trial among HIV-infected women.PLoS One. 2014;9:e87855-e87855
72. Hamilton ST, van Zuylen W, Naing Z, et al. Prevention of congenital cytomegalovirus by maternal and neonatal treatments: A systematic review. Reviews in Medical Virology. In press 2014.
73. Nigro G,Adler SP,La Torre R,.Passive immunization during pregnancy for congenital cytomegalovirus infection.N Engl J Med. 2005;353:1350-1362
74. Buxmann H,Stackelberg OM,Schlosser RL,.Use of cytomegalovirus hyperimmunoglobulin for prevention of congenital cytomegalovirus disease: A retrospective analysis.J Perinat Med. 2012;40:439-446
75. Nigro G,Adler SP,Parruti G,.Immunoglobulin therapy of fetal cytomegalovirus infection occurring in the first half of pregnancy—A case-control study of the outcome in children.J Infect Dis. 2012;205:215-227
76. Visentin S,Manara R,Milanese L,.Early primary cytomegalovirus infection in pregnancy: maternal hyperimmunoglobulin therapy improves outcomes among infants at 1 year of age.Clin Infect Dis. 2012;55:497-503
77. A trial of immunoglobulin fetal therapy for symptomatic congenital cytomegalovirus infection.J Reprod Immunol. 2012;95:73-79
78. Revello MG,Lazzarotto T,Guerra B,.A randomized trial of hyperimmune globulin to prevent congenital cytomegalovirus.N Engl J Med. 2014;370:1316-1326
79. Nigro G, Capretti I, Manganello AM, et al. Primary maternal cytomegalovirus infections during pregnancy: Association of CMV hyperimmune globulin with gestational age at birth and birth weight. J Matern Fetal Neonatal Med 2014; 1–4.
80. Interim analysis of the Cytotec Phase III trial in congenial cytomegalovirus (CMV) infection shows clear indication of efficacy, http://www.biotest.com/ww/en/pub/investor_relations/news/newsdetails.cfm?newsID=1025191 (accessed September 2014).
81. Adler SP,Finney JW,Manganello AM,.Prevention of child-to-mother transmission of cytomegalovirus by changing behaviors: A randomized controlled trial.Pediatr Infect Dis J. 1996;15:240-246
82. Adler SP,Finney JW,Manganello AM,.Prevention of child-to-mother transmission of cytomegalovirus among pregnant women.J Pediatr. 2004;145:485-491
83. Picone O,Vauloup-Fellous C,Cordier AG,.A 2-year study on cytomegalovirus infection during pregnancy in a French hospital.BJOG. 2009;116:818-823
84. Cannon MJ,Davis KF.Washing our hands of the congenital cytomegalovirus disease epidemic.BMC Public Health. 2005;5:70-70
85. ACOG practice bulletin. Perinatal viral and parasitic infections.Int J Gynaecol Obstet. 2002;76:95-107
86. Centers for Disease Control and Prevention. Cytomegalovirus and congenital infection—prevention, http://www.cdc.gov/cmv/prevention.html (accessed September 2014).